CD, B., Y, T., M, C., RV, V., G, D., N, A., & S, P. (2024). Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review. ClinicoEconomics and outcomes research : CEOR, 16, 447. https://doi.org/10.2147/CEOR.S460912
Chicago Style (17th ed.) CitationCD, Burger, Tsang Y, Chivers M, Vekaria RV, Doad G, Atkins N, and Panjabi S. "Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review." ClinicoEconomics and Outcomes Research : CEOR 16 (2024): 447. https://doi.org/10.2147/CEOR.S460912.
MLA (9th ed.) CitationCD, Burger, et al. "Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review." ClinicoEconomics and Outcomes Research : CEOR, vol. 16, 2024, p. 447, https://doi.org/10.2147/CEOR.S460912.
Warning: These citations may not always be 100% accurate.